Sean F. Scanlan, Chief Innovation Officer of Treace Medical Concepts, Inc., filed a statement of changes in beneficial ownership on October 28, 2026, reporting a transaction dated October 24, 2026.

Key Highlights

  • Reporting person: Sean F. Scanlan, Chief Innovation Officer of Treace Medical Concepts, Inc. (NASDAQ:TMCI)
  • Transaction code F: 207 shares of common stock were disposed of at a price of $0 on October 24, 2026
  • Domestic relations order: 45,000 shares of common stock were transferred to Scanlan's former spouse pursuant to a domestic relations order, per footnote 2 of the filing
  • Beneficial ownership following transaction: 634,656 shares of common stock held directly, including 462,317 restricted stock units per footnote 1
  • Filing signed: Lisa Taylor as attorney-in-fact for Sean Scanlan, dated October 28, 2026

Sean Scanlan's Ownership Change at Treace Medical Concepts

According to the filing, Sean F. Scanlan, who serves as Chief Innovation Officer at Treace Medical Concepts, Inc. (NASDAQ:TMCI), reported a disposition of 207 shares of common stock on October 24, 2026, under transaction code F, at a price of $0. Treace Medical Concepts is a medical device company focused on surgical solutions for bunion correction.

The filing also discloses, via footnote 2, that 45,000 shares of common stock were transferred to Scanlan's former spouse pursuant to a domestic relations order. Following all reported transactions, Scanlan's direct beneficial ownership stands at 634,656 shares of common stock. As noted in footnote 1, that total includes 462,317 restricted stock units. No derivative securities were reported in Table II of the filing.

The filing was submitted by Lisa Taylor as attorney-in-fact for Sean Scanlan and is indicated as filed by one reporting person. The date of earliest transaction is listed as October 24, 2026, and the form was filed on October 28, 2026.

What Was Disclosed

The filing reported a disposition of 207 shares at $0 under transaction code F and disclosed a transfer of 45,000 shares to Scanlan's former spouse under a domestic relations order, leaving direct beneficial ownership at 634,656 shares, including 462,317 restricted stock units.